BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer-Reference-Cited by-同舟云学术

BRCA mutation carrier detection. A model-based cost-effectiveness analysis comparing the traditional family history approach and the testing of all patients with breast cancer

Published:2018 Issue:3 Volume:3 Page:e000328
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Norum Jan,Grindedal Eli Marie,Heramb Cecilie,Karsrud Inga,Ariansen Sarah Louise,Undlien Dag Erik,Schlichting Ellen,Mæhle Lovise

Funder

UiT - The arctic university of Norway

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference37 articles.

1. Clinical practice guidelines for the prevention and early detection of breast and ovarian cancer in women from HBOC (hereditary breast and ovarian cancer) families;Singer;Wien Klin Wochenschr,2015

2. Prophylactic bilateral salpingo-oophorectomy (PBSO) with or without prophylactic bilateral mastectomy (PBM) or no intervention in BRCA1 mutation carriers: a cost-effectiveness analysis;Norum;Eur J Cancer,2008

3. Linkage of early-onset familial breast cancer to chromosome 17q21;Hall;Science,1990

4. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1;Miki;Science,1994

5. Population-based screening for BRCA1 and BRCA2: 2014 Lasker Award;King;JAMA,2014

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BRCA genetic testing and counseling in breast cancer: how do we meet our patients’ needs?;npj Breast Cancer;2024-09-05

2. Economic evaluation of germline genetic testing for breast cancer in low- and middle-income countries: a systematic review;BMC Cancer;2024-03-07

3. Testing for Inherited Susceptibility to Breast Cancer;Hematology/Oncology Clinics of North America;2023-02

4. The economic value of knowing BRCA status: universal BRCA testing for breast cancer prevention;Expert Review of Pharmacoeconomics & Outcomes Research;2023-01-29

5. Cost-Effectiveness of Genetic Testing Strategies for Breast Cancer;Screening and Risk Reduction Strategies for Breast Cancer;2023